trimetazidine has been researched along with novolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Aubaidy, HA; Amber, KI; Hadi, NR; Jamil, DA; Muhammad-Baqir, BM | 1 |
1 trial(s) available for trimetazidine and novolimus
Article | Year |
---|---|
Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation.
Topics: Absorbable Implants; Adult; Aged; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Inflammation; Inflammation Mediators; Macrolides; Male; Middle Aged; Percutaneous Coronary Intervention; Single-Blind Method; Tissue Scaffolds; Trimetazidine; Vasodilator Agents | 2016 |